First Trust NYSE Arca Biotechnology UCITS 

GBX2,569.50
3
+GBX11.00+0.43%Friday 15:14

Statistics

Day High
2,584.75
Day Low
2,525.5
52W High
2,589
52W Low
1,745.71
Volume
6,310.98
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Expense Ratio

0.60%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF is a direct competitor, focusing on NASDAQ-listed biotechnology and pharmaceutical companies, similar to FBTU's biotech focus.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF tracks an equal-weighted index of US biotechnology stocks, competing directly in the biotech investment space.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF includes holdings in major biotech firms, directly competing with FBTU's investment strategy in biotechnology sector.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund is another biotech-focused fund from First Trust, targeting similar companies and potentially overlapping with FBTU.
Principal Healthcare Innovators Index
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF focuses on US healthcare innovation, including biotechnology, competing for similar investor interest.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF offers exposure to the biotech and genome sector, competing in the same niche as FBTU.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF invests in small-cap companies in the medical sector, including biotech, competing for similar growth-focused investments.
Virtus Biotech Clinical Trials
BBC
Mkt Cap0
Virtus LifeSci Biotech Clinical Trials ETF focuses on biotechnology companies in clinical trials, a specific segment also targeted by FBTU.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF is focused on the genomics and biotech sectors, competing with FBTU in the biotech investment theme.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF invests in the broader genomics industry, which includes biotechnology, competing indirectly with FBTU's focus area.

Holdings

Regions

Sectors

About

The Fund seeks investment results that correspond generally to the price and yield (before the Funds fees
Show More
CEO
Country
Ireland
ISIN
IE00BL0L0H60

Listings

0 Comments

Share your thoughts

FAQs

What is First Trust NYSE Arca Biotechnology UCITS stock price today?▼
The current price of FBT.LSE is GBX2,569.50 GBX — it has increased by +0.43% in the past 24 hours. Watch First Trust NYSE Arca Biotechnology UCITS stock price performance more closely on the chart.
What is First Trust NYSE Arca Biotechnology UCITS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange First Trust NYSE Arca Biotechnology UCITS stocks are traded under the ticker FBT.LSE.
Is First Trust NYSE Arca Biotechnology UCITS stock price growing?▼
FBT.LSE stock has risen by +4.15% compared to the previous week, the month change is a +2.48% rise, over the last year First Trust NYSE Arca Biotechnology UCITS has showed a +44.05% increase.
In which sector is First Trust NYSE Arca Biotechnology UCITS located?▼
First Trust NYSE Arca Biotechnology UCITS operates in the Finance & Payments sector.
When did First Trust NYSE Arca Biotechnology UCITS complete a stock split?▼
First Trust NYSE Arca Biotechnology UCITS has not had any recent stock splits.
Where is First Trust NYSE Arca Biotechnology UCITS headquartered?▼
First Trust NYSE Arca Biotechnology UCITS is headquartered in Dublin, Ireland.